Active Ingredient(s): Florbetaben
FDA Approved: * March 19, 2014
Pharm Company: * PIRAMAL IMAGING
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Neuraceq Overview

Florbetaben, a fluorine-18 (18F)-labeled stilbene derivative (formerly known as BAY-949172), trade name NeuraCeq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment. ^...

Read more Neuraceq Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Neuraceq Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 50 To 5000mbq/ml
  • Solution: 30ml (1.4-135mci/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Neuraceq: (1 result)

Sorted by National Drug Code
  • 54828-001 Neuraceq 135 mci/Ml Intravenous Injection, Solution by Piramal Imaging, Sa

Other drugs which contain Florbetaben or a similar ingredient: (1 result)